These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4563872)

  • 21. Surgical adjuvant trials in the United States.
    Rozencweig M; Von Hoff DD; Allegra JC; Muggia FM
    Eur J Cancer (1965); 1980; Suppl 1():173-7. PubMed ID: 7032929
    [No Abstract]   [Full Text] [Related]  

  • 22. Does outcome of breast cancer depend on dose and dose intensity of adjuvant chemotherapy?
    Mittra I
    Natl Med J India; 1994; 7(5):221-2. PubMed ID: 7827602
    [No Abstract]   [Full Text] [Related]  

  • 23. [Adjuvant chemotherapy of breast neoplasms. Review of the up-to-date results of various studies including the Heidelberg study].
    Queisser W
    Fortschr Med; 1980 Feb; 98(8):286-8. PubMed ID: 7380378
    [No Abstract]   [Full Text] [Related]  

  • 24. DPD activity and immunohistochemical DPD expression in human breast cancer.
    Horiguchi J; Yoshida T; Koibuchi Y; Iijima K; Ninomiya J; Takei H; Yokoe T; Iino Y; Morishita Y
    Oncol Rep; 2004 Jan; 11(1):65-72. PubMed ID: 14654904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trials of adjuvant chemotherapy in breast cancer. The experience of the Istituto Nazionale Tumori of Milan.
    Rossi A; Bonadonna G; Tancini G; Bajetta E; Marchini S; Valagussa P; Veronesi U
    Eur J Cancer (1965); 1980; Suppl 1():149-56. PubMed ID: 7032924
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of metastatic carcinoma of the female breast with combination of hormones and other chemotherapy.
    Firat D; Olshin S
    Cancer Chemother Rep; 1968 Dec; 52(7):743-50. PubMed ID: 5743711
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of metastases of breast cancer by an immediate combination of hormonal treatment and chemotherapy with nonhormonal cytostatics].
    Mannes P; Derriks R
    Acta Tuberc Pneumol Belg; 1968; 59(2):445-54. PubMed ID: 5720490
    [No Abstract]   [Full Text] [Related]  

  • 28. Correlation between HER-2 expression and response to neoadjuvant chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide in patients with breast carcinoma.
    Zhang F; Yang Y; Smith T; Kau SW; McConathy JM; Esteva FJ; Kuerer HM; Symmans WF; Buzdar AU; Hortobagyi GN; Pusztai L
    Cancer; 2003 Apr; 97(7):1758-65. PubMed ID: 12655533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy before mastectomy may be a more effective therapeutic sequence than its reverse in primary operable breast cancer.
    Papaioannou AN
    Eur J Cancer (1965); 1980; Suppl 1():255-8. PubMed ID: 7032938
    [No Abstract]   [Full Text] [Related]  

  • 30. [Differential effect of fractionated irradiation and the administration of 5-fluorouracil on a mammary tumor in the BALB/c/Cnb mouse].
    Maisin H; Anckaert MA; De Coster B
    C R Seances Soc Biol Fil; 1983; 177(1):116-9. PubMed ID: 6221779
    [No Abstract]   [Full Text] [Related]  

  • 31. Concepts for controlling drug-resistant tumor cells.
    Schabel FM; Skipper HE; Trader MW; Laster WR; Corbett TH; Griswold DP
    Eur J Cancer (1965); 1980; Suppl 1():199-211. PubMed ID: 6947891
    [No Abstract]   [Full Text] [Related]  

  • 32. Combination therapy of 3-methylcholanthrene-induced mammary carcinoma in rats: effect of chemotherapy, ovariectomy, and food restriction.
    Gropper L; Shimkin MB
    Cancer Res; 1967 Jan; 27(1):26-32. PubMed ID: 6071371
    [No Abstract]   [Full Text] [Related]  

  • 33. [Polychemotherapeutic treatment of pulmonary neoplasms].
    Dorigoni A; Peris GC; Scarponi F; Alcozer G
    G Pneumol; 1970 Jun; 14(3):164-92. PubMed ID: 5526216
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of endocrine regulation of growth of a mouse mammary tumor on its sensitivity to chemotherapy.
    Emerman JT; Siemiatkowski J
    Cancer Res; 1984 Apr; 44(4):1327-32. PubMed ID: 6704951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant chemotherapy, anti-estrogen therapy and immunotherapy for stage II breast cancer.
    Hubay CA; Pearson OH; Marshall JS; Rhodes RS; Debanne SM; Mansour EG; Hermann RE; Jones JC; Flynn WJ; Eckert C; McGuire WL
    Eur J Cancer (1965); 1980; Suppl 1():189-95. PubMed ID: 7032932
    [No Abstract]   [Full Text] [Related]  

  • 36. [Chemotherapy of breast cancer].
    Sakai K
    Geka Chiryo; 1969 Aug; 21(2):207-18. PubMed ID: 4982958
    [No Abstract]   [Full Text] [Related]  

  • 37. The case for adjuvant CMF chemotherapy in breast cancer. Has it been made?
    Levitt SH; Potish RA
    Cancer Clin Trials; 1981; 4(4):363-9. PubMed ID: 7032731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemoendocrine therapy in advanced breast cancer.
    Kiang DT; Kennedy BJ
    Breast Cancer Res Treat; 1981; 1(2):105-9. PubMed ID: 6816316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy.
    Lin YC; Chen SC; Chang HK; Hsueh S; Tsai CS; Lo YF; Hwang TL; Chen MF
    Jpn J Clin Oncol; 2005 Sep; 35(9):514-9. PubMed ID: 16199422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Influence of cyclophosphamide, ribo-azauracil and mercaleukin pretreatment on experimental metastasizing in a syngenic tumor-host system. I. Spontaneous breast carcinoma of the mouse].
    Nowak C; Elbe B; Arnold W; Bender E
    Arch Geschwulstforsch; 1973; 41(1):1-11. PubMed ID: 4700692
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.